A clinic to help patients with liver disease avoid hospital readmissions
The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission
This study is looking at how a special clinic can help people with liver cirrhosis and alcoholic hepatitis stay healthy after leaving the hospital, by checking in with them through phone calls and online visits to make sure they’re managing their medications and getting the right care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10992619 on NIH RePORTER |
What this research studies
This research focuses on improving the care of patients with liver cirrhosis and alcoholic hepatitis to reduce hospital readmissions. It involves a Transitional Liver Clinic (TLC) where patients are contacted shortly after discharge from the hospital to ensure proper medication management and communication with healthcare providers. The TLC program includes follow-up phone calls and telehealth visits to address complications and optimize treatment plans. By enhancing transitional care, the program aims to provide better support for patients during their recovery period.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with liver cirrhosis or alcoholic hepatitis who have recently been discharged from the hospital.
Not a fit: Patients who do not have liver disease or those who are not recently discharged from the hospital may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rate of hospital readmissions for patients with advanced liver disease.
How similar studies have performed: Previous research has shown that transitional care programs have successfully improved outcomes in other conditions, although there is limited data specifically for patients with advanced liver disease.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Orman, Eric — Indiana University Indianapolis
- Study coordinator: Orman, Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.